Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Published:August 24, 2020DOI:
      The aim of this study was to estimate the incidence of COVID-19 disease in the French national population of dialysis patients, their course of illness and to identify the risk factors associated with mortality. Our study included all patients on dialysis recorded in the French REIN Registry in April 2020. Clinical characteristics at last follow-up and the evolution of COVID-19 illness severity over time were recorded for diagnosed cases (either suspicious clinical symptoms, characteristic signs on the chest scan or a positive reverse transcription polymerase chain reaction) for SARS-CoV-2. A total of 1,621 infected patients were reported on the REIN registry from March 16th, 2020 to May 4th, 2020. Of these, 344 died. The prevalence of COVID-19 patients varied from less than 1% to 10% between regions. The probability of being a case was higher in males, patients with diabetes, those in need of assistance for transfer or treated at a self-care unit. Dialysis at home was associated with a lower probability of being infected as was being a smoker, a former smoker, having an active malignancy, or peripheral vascular disease. Mortality in diagnosed cases (21%) was associated with the same causes as in the general population. Higher age, hypoalbuminemia and the presence of an ischemic heart disease were statistically independently associated with a higher risk of death. Being treated at a selfcare unit was associated with a lower risk. Thus, our study showed a relatively low frequency of COVID-19 among dialysis patients contrary to what might have been assumed.

      Graphical abstract


      To read this article in full you will need to make a payment
      ISN Member Login
      Login with your ISN username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Basile C.
        • Combe C.
        • Pizzarelli F.
        • et al.
        Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres.
        Nephrol Dial Transplant. 2020; 35: 737-741
        • Kliger A.S.
        • Silberzweig J.
        Mitigating risk of COVID-19 in dialysis facilities.
        Clin J Am Soc Nephrol. 2020; 15: 707-709
        • Burgner A.
        • Ikizler T.A.
        • Dwyer J.P.
        COVID-19 and the inpatient dialysis unit: managing resources during contingency planning pre-crisis.
        Clin J Am Soc Nephrol. 2020; 15: 720-722
        • Shen Q.
        • Wang M.
        • Che R.
        • et al.
        Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic.
        Pediatr Nephrol. 2020; 35: 1351-1357
        • Kissling S.
        • Pruijm M.
        [COVID-19 from the nephrologist’s point of view].
        Rev Med Suisse. 2020; 16: 842-844
        • Harwood L.
        Pandemic uncertainty: considerations for nephrology nurses.
        Nephrol Nurs J. 2020; 47: 127-130
        • Su K.
        • Ma Y.
        • Wang Y.
        • et al.
        How we mitigated and contained the COVID-19 outbreak in a hemodialysis center: lessons and experiences.
        Infect Control Hosp Epidemiol. 2020; 41: 1240-1242
        • Ferrey A.J.
        • Choi G.
        • Hanna R.M.
        • et al.
        A case of novel coronavirus disease 19 in a chronic hemodialysis patient presenting with gastroenteritis and developing severe pulmonary disease.
        Am J Nephrol. 2020; 51: 337-342
        • Tang B.
        • Li S.
        • Xiong Y.
        • et al.
        COVID-19 pneumonia in a hemodialysis patient.
        Kidney Med. 2020; 2: 354-358
      1. Schwierzeck V, König JC, Kühn J, et al. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit [e-pub ahead of print]. Clin Infect Dis. Accessed November 3, 2020.

        • El Shamy O.
        • Sharma S.
        • Winston J.
        • Uribarri J.
        Peritoneal dialysis during the coronavirus 2019 (COVID-19) pandemic: acute inpatient and maintenance outpatient experiences.
        Kidney Med. 2020; 2: 377-380
        • Basile C.
        An analysis on the clinical features of MHD patients with coronavirus disease 2019: a single center study.
        (Available at:) (Accessed November 3, 2020)
        • Dudreuilh C.
        • Kumar N.
        • Moxham V.
        • et al.
        De-isolation of COVID-19–positive hemodialysis patients in the outpatient setting: a single-center experience.
        Kidney Int. 2020; 98: 236-237
        • Alberici F.
        • Delbarba E.
        • Manenti C.
        • et al.
        Management of patients on dialysis and with kidney transplant during SARS-COV-2 (COVID-19) pandemic in Brescia, Italy.
        Kidney Int Rep. 2020; 5: 580-585
        • Goicoechea M.
        • Sánchez Cámara L.A.
        • Macías N.
        • et al.
        COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.
        Kidney Int. 2020; 98: 27-34
        • Valeri A.M.
        • Robbins-Juarez S.Y.
        • Stevens J.S.
        • et al.
        Presentation and outcomes of patients with ESKD and COVID-19.
        J Am Soc Nephrol. 2020; 31: 1409-1415
        • Li J.
        • Xu G.
        Lessons from the experience in Wuhan to reduce risk of COVID-19 infection in patients undergoing long-term hemodialysis.
        Clin J Am Soc Nephrol. 2020; 15: 717-719
      2. Société Francophone de Nephrology Dialyse Transplantation.
        (Available at:) (Accessed November 3, 2020)
        • Cho J.-H.
        • Kang S.H.
        • Park H.C.
        • et al.
        Hemodialysis with cohort isolation to prevent secondary transmission during a COVID-19 outbreak in Korea.
        J Am Soc Nephrol. 2020; 31: 1398-1408
        • Vardavas C.I.
        • Nikitara K.
        COVID-19 and smoking: a systematic review of the evidence.
        Tob Induc Dis. 2020; 18: 20
        • Phirtskhalaishvili T.
        • Bayer F.
        • Edet S.
        • et al.
        Spatial analysis of case-mix and dialysis modality associations.
        Perit Dial Int. 2016; 36: 326-333
        • Onder G.
        • Rezza G.
        • Brusaferro S.
        Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy.
        JAMA. 2020; 323: 1775-1776
        • Williamson E.
        • Walker A.J.
        • et al.
        • OpenSAFELY Collaborative
        OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
        (Available at:) (Accessed May 10, 2020)
        • Siddiqi H.K.
        • Mehra M.R.
        COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal.
        J Heart Lung Transplant. 2020; 39: 405-407
        • Couchoud C.
        • Stengel B.
        • Landais P.
        • et al.
        The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.
        Nephrol Dial Transplant. 2006; 21: 411-418
        • World Health Organization
        COVID-19 therapeutic trial synopsis.
        (Available at:) (Accessed April 1, 2020)
      3. Santé Publique France.
        (Available at:) (Accessed November 3, 2020)

      Linked Article